Outcomes following subcutaneous and intravenous treatment with lecanemab for Alzheimer’s disease were comparable, according ...

Gov. Bill Lee refuses to review Tennessee's lethal injection protocol after a failed execution attempt.

Tennessee's lethal injection protocol adopted a year and a half ago appears to include reduced training in IV placement. That ...

BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai today presented new data at the 2026 Alzheimer's Association ...

Eisai Co., Ltd. and Biogen Inc. (Nasdaq: BIIB) announced today that new data presented at the Alzheimer’s Association International Conference ® (AAIC ®) 2026 in London support that the LEQEMBI ® ...

New clinical and real-world data support a subcutaneous treatment pathway from initiation through maintenance treatment, offering dosing convenience for patients and ...

Sanofi (SNY) wins FDA approval for Sarclisa Escena, a subcutaneously-delivered version of its multiple myeloma therapy ...

The U.S. Food and Drug Administration said on Friday it has approved a wearable form of Sanofi's blood cancer drug, Sarclisa, ...

Sanofi has scored FDA approval for its subcutaneous version of Sarclisa, giving the multiple myeloma treatment a potential ...

It’s unlikely Gov. Bill Lee will call a death penalty moratorium before Tennessee’s next execution. Calls for a temporary ...

The U.S. FDA has approved Sanofi's Sarclisa, a blood cancer drug, in a groundbreaking wearable form to aid multiple myeloma ...

Seattle-based Providence Swedish group of doctors is testing the novel treatment for glioblastoma, one of the deadliest forms ...